[English] 日本語
Yorodumi- EMDB-61180: Cryo-EM structure of human dopamine transporter in complex with d... -
+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Cryo-EM structure of human dopamine transporter in complex with dasotraline | |||||||||
Map data | ||||||||||
Sample |
| |||||||||
Keywords | Cryo-EM structure of human dopamine transporter in complex with dasotraline / MEMBRANE PROTEIN | |||||||||
| Function / homology | Function and homology informationDefective neurotransmitter clearance by SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) / Defective transport of neurotransmitters by SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) / Dopamine clearance from the synaptic cleft / amine binding / hyaloid vascular plexus regression / dopamine uptake / dopamine binding / norepinephrine:sodium symporter activity / dopamine:sodium symporter activity / response to leptin ...Defective neurotransmitter clearance by SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) / Defective transport of neurotransmitters by SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) / Dopamine clearance from the synaptic cleft / amine binding / hyaloid vascular plexus regression / dopamine uptake / dopamine binding / norepinephrine:sodium symporter activity / dopamine:sodium symporter activity / response to leptin / neurotransmitter transmembrane transporter activity / flotillin complex / monoamine transmembrane transporter activity / dopaminergic synapse / SLC-mediated transport of neurotransmitters / response to iron ion / heterocyclic compound binding / dopamine uptake involved in synaptic transmission / neurotransmitter transport / amino acid transport / response to cAMP / protein phosphatase 2A binding / axon terminus / response to nicotine / sodium ion transmembrane transport / protease binding / presynaptic membrane / response to ethanol / neuron projection / postsynaptic membrane / response to xenobiotic stimulus / membrane raft / signaling receptor binding / axon / neuronal cell body / protein-containing complex binding / cell surface / membrane / plasma membrane / cytoplasm Similarity search - Function | |||||||||
| Biological species | Homo sapiens (human) | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 3.2 Å | |||||||||
Authors | Zhao Y / Li Y | |||||||||
| Funding support | China, 1 items
| |||||||||
Citation | Journal: Nat Commun / Year: 2025Title: Structural basis for pharmacotherapeutic action of triple reuptake inhibitors. Authors: Yue Li / Yufei Meng / Na Li / Jun Zhao / Renjie Li / Qinru Bai / Gang Wang / Yan Zhao / ![]() Abstract: Most first-line pharmacotherapeutic strategies for depression aim to boost serotonin and norepinephrine levels. However, 35% of patients with depression do not respond adequately to these treatments ...Most first-line pharmacotherapeutic strategies for depression aim to boost serotonin and norepinephrine levels. However, 35% of patients with depression do not respond adequately to these treatments or experience adverse side effects. The serotonin-norepinephrine-dopamine reuptake inhibitors, also known as triple reuptake inhibitors (TRIs), are emerging as promising antidepressants with greater potency and fewer side effects. Here, we determine an ensemble of structures of DAT in complex with five distinct TRIs. Tesofensine and dasotraline stabilize DAT in an outward-facing conformation, while centanafadine, ansofaxine, and nefazodone capture the inward-facing conformation. These structures reveal binding poses and interactions involved in the association of inhibitors. Notably, ansofaxine binds at a location which is much closer to the intracellular membrane surface. Through extensive structural analysis, we establish a comprehensive blueprint for the association of these TRIs, which is crucial for future drug development aimed at achieving potent antidepressant with fewer side effect. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_61180.map.gz | 59.7 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-61180-v30.xml emd-61180.xml | 19.8 KB 19.8 KB | Display Display | EMDB header |
| Images | emd_61180.png | 114.4 KB | ||
| Filedesc metadata | emd-61180.cif.gz | 6.4 KB | ||
| Others | emd_61180_half_map_1.map.gz emd_61180_half_map_2.map.gz | 59.3 MB 59.3 MB | ||
| Archive directory | https://data.pdbj.org/pub/emdb/structures/EMD-61180 ftp://data.pdbj.org/pub/emdb/structures/EMD-61180 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 9j6rMC ![]() 9j6sC ![]() 9j6tC ![]() 9j6uC ![]() 9j6vC ![]() 9vwrC ![]() 9vwsC M: atomic model generated by this map C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|---|
| Related items in Molecule of the Month |
-
Map
| File | Download / File: emd_61180.map.gz / Format: CCP4 / Size: 64 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.85 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Half map: #2
| File | emd_61180_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: #1
| File | emd_61180_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : Cryo-EM structure of human dopamine transporter in complex with d...
| Entire | Name: Cryo-EM structure of human dopamine transporter in complex with dasotraline |
|---|---|
| Components |
|
-Supramolecule #1: Cryo-EM structure of human dopamine transporter in complex with d...
| Supramolecule | Name: Cryo-EM structure of human dopamine transporter in complex with dasotraline type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1 |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
-Macromolecule #1: Sodium-dependent dopamine transporter
| Macromolecule | Name: Sodium-dependent dopamine transporter / type: protein_or_peptide / ID: 1 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 62.465449 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: DRETWGKKID FLLSVIGFAV DLANVWRFPY LCYKNGGGAF LVPYLLFMVI AGMPLFYMEL ALGQFNREGA AGVWKICPIL KGVGFTVIL ISLYVGFFYN VIIAWALHYL FSSFTTELPW IHCNNSWNSP NCSDAHPGDS SGDSSGLNDT FGTTPAAEYF E RGVLHLHQ ...String: DRETWGKKID FLLSVIGFAV DLANVWRFPY LCYKNGGGAF LVPYLLFMVI AGMPLFYMEL ALGQFNREGA AGVWKICPIL KGVGFTVIL ISLYVGFFYN VIIAWALHYL FSSFTTELPW IHCNNSWNSP NCSDAHPGDS SGDSSGLNDT FGTTPAAEYF E RGVLHLHQ SHGIDDLGPP RWQLTACLVL VIVLLYFSLW KGVKTSGKVV WITATMPYVV LTALLLRGVT LPGAIDGIRA YL SVDFYRL CEASVWIDAA TQVCFSLGVG FGVLIAFSSY NKFTNNCYRD AIVTTSINSL TSFSSGFVVF SFLGYMAQKH SVP IGDVAK DGPGLIFIIY PEAIATLPLS SAWAVVFFIM LLTLGIDSAM GGMESVITGL IDEFQLLHRH RELFTLFIVL ATFL LSLFC VTNGGIYVFT LLDHFAAGTS ILFGVLIEAI GVAWFYGVGQ FSDDIQQMTG QRPSLYWRLC WKLVSPCFLL FVVVV SIVT FRPPHYGAYI FPDWANALGW VIATSSMAMV PIYAAYKFCS LPGSFREKLA YAIAPEKDRE LVDRGEVRQF TLRHWL KV UniProtKB: Sodium-dependent dopamine transporter |
-Macromolecule #2: (1~{R},4~{S})-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen...
| Macromolecule | Name: (1~{R},4~{S})-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine type: ligand / ID: 2 / Number of copies: 1 / Formula: A1EA0 |
|---|---|
| Molecular weight | Theoretical: 292.203 Da |
-Macromolecule #3: CHLORIDE ION
| Macromolecule | Name: CHLORIDE ION / type: ligand / ID: 3 / Number of copies: 1 / Formula: CL |
|---|---|
| Molecular weight | Theoretical: 35.453 Da |
-Macromolecule #4: CHOLESTEROL
| Macromolecule | Name: CHOLESTEROL / type: ligand / ID: 4 / Number of copies: 1 / Formula: CLR |
|---|---|
| Molecular weight | Theoretical: 386.654 Da |
| Chemical component information | ![]() ChemComp-CLR: |
-Macromolecule #5: CHOLESTEROL HEMISUCCINATE
| Macromolecule | Name: CHOLESTEROL HEMISUCCINATE / type: ligand / ID: 5 / Number of copies: 1 / Formula: Y01 |
|---|---|
| Molecular weight | Theoretical: 486.726 Da |
| Chemical component information | ![]() ChemComp-Y01: |
-Macromolecule #6: water
| Macromolecule | Name: water / type: ligand / ID: 6 / Number of copies: 1 / Formula: HOH |
|---|---|
| Molecular weight | Theoretical: 18.015 Da |
| Chemical component information | ![]() ChemComp-HOH: |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Buffer | pH: 7.5 |
|---|---|
| Vitrification | Cryogen name: ETHANE |
-
Electron microscopy
| Microscope | TFS KRIOS |
|---|---|
| Image recording | Film or detector model: GATAN K3 (6k x 4k) / Average electron dose: 60.0 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.0 µm / Nominal defocus min: 1.0 µm |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
Movie
Controller
About Yorodumi



Keywords
Homo sapiens (human)
Authors
China, 1 items
Citation















Z (Sec.)
Y (Row.)
X (Col.)







































Processing
FIELD EMISSION GUN

